Mitoxantrone in combination with a DNA-PK inhibitor: possible therapy of promyelocytic leukaemia resistant forms. [electronic resource]
Producer: 20120605Description: 200-5 p. digitalISSN:- 0015-5500
- Acid Anhydride Hydrolases
- Antineoplastic Agents -- pharmacology
- Cell Cycle Proteins -- genetics
- DNA Breaks, Double-Stranded
- DNA End-Joining Repair
- DNA Repair Enzymes -- genetics
- DNA-Activated Protein Kinase -- antagonists & inhibitors
- DNA-Binding Proteins -- genetics
- Drug Resistance, Neoplasm
- Drug Synergism
- HL-60 Cells -- drug effects
- Homologous Recombination
- Humans
- Leukemia, Promyelocytic, Acute -- drug therapy
- Mitoxantrone -- pharmacology
- Nuclear Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.